121 related articles for article (PubMed ID: 3449085)
1. Amsacrine analogues with extended chromophores: DNA binding and anti-tumour activity.
Denny WA; Baguley BC
Anticancer Drug Des; 1987 Aug; 2(1):61-70. PubMed ID: 3449085
[TBL] [Abstract][Full Text] [Related]
2. 'Minimal' DNA-intercalating agents as anti-tumour drugs: 2-styrylquinoline analogues of amsacrine.
Denny WA; Atwell GJ; Baguley BC
Anticancer Drug Des; 1987 Dec; 2(3):263-70. PubMed ID: 3449090
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo assessment of activity of new anilino-substituted analogues of amsacrine against Lewis lung carcinoma.
Rewcastle GW; Denny WA; Wilson WR; Baguley BC
Anticancer Drug Des; 1986 Nov; 1(3):215-22. PubMed ID: 3450294
[TBL] [Abstract][Full Text] [Related]
4. Steric constraints for DNA binding and biological activity in the amsacrine series.
Denny WA; Twigden SJ; Baguley BC
Anticancer Drug Des; 1986 Apr; 1(2):125-32. PubMed ID: 3450288
[TBL] [Abstract][Full Text] [Related]
5. Relationship between DNA-binding and biological activity of anilinoacridine derivatives containing the nucleic acid-binding unit SPKK.
Bailly F; Bailly C; Helbecque N; Pommery N; Colson P; Houssier C; Hénichart JP
Anticancer Drug Des; 1992 Feb; 7(1):83-100. PubMed ID: 1543529
[TBL] [Abstract][Full Text] [Related]
6. Design of two metal-chelating, DNA-binding models: molecular combinations of bleomycin and amsacrine anti-tumour drugs.
Bailly C; Bernier JL; Houssin R; Helbecque N; Hénichart JP
Anticancer Drug Des; 1987 Apr; 1(4):303-12. PubMed ID: 2453198
[TBL] [Abstract][Full Text] [Related]
7. Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
J Med Chem; 1987 Apr; 30(4):652-8. PubMed ID: 3560159
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of novel amsacrine analogs: the critical role of the acridine moiety in determining their biological activity.
Chilin A; Marzaro G; Marzano C; Dalla Via L; Ferlin MG; Pastorini G; Guiotto A
Bioorg Med Chem; 2009 Jan; 17(2):523-9. PubMed ID: 19101158
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic and DNA binding properties of aminoalkyl derivatives of di- and triazaphenanthrenes.
Argiropoulos G; Bates MR; Cherubim P; Deady LW; Ganakas AM; Baguley BC; Denny WA
Anticancer Drug Des; 1992 Aug; 7(4):285-96. PubMed ID: 1510798
[TBL] [Abstract][Full Text] [Related]
10. Potential antitumor agents. 52. Carbamate analogues of amsacrine with in vivo activity against multidrug-resistant P388 leukemia.
Rewcastle GW; Baguley BC; Atwell GJ; Denny WA
J Med Chem; 1987 Sep; 30(9):1576-81. PubMed ID: 3625706
[TBL] [Abstract][Full Text] [Related]
11. Potential antitumor agents. 42. Structure-activity relationships for acridine-substituted dimethyl phosphoramidate derivatives of 9-anilinoacridine.
Rewcastle GW; Atwell GJ; Baguley BC; Denny WA
J Med Chem; 1984 Aug; 27(8):1053-6. PubMed ID: 6747989
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor activity of pyrido-amsacrine analogues and related compounds.
Llama E; Del Campo C; Capo M; Anadon M
J Pharm Sci; 1993 Mar; 82(3):262-5. PubMed ID: 8450419
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
Baguley BC; Wilson WR
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):607-13. PubMed ID: 3653185
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the action of the topoisomerase II poison amsacrine by simple aniline derivatives: evidence for drug-protein interactions.
Finlay GJ; Atwell GJ; Baguley BC
Oncol Res; 1999; 11(6):249-54. PubMed ID: 10691026
[TBL] [Abstract][Full Text] [Related]
16. Potent antitumor N-mustard derivatives of 9-anilinoacridine, synthesis and antitumor evaluation.
Bacherikov VA; Chou TC; Dong HJ; Chen CH; Lin YW; Tsai TJ; Su TL
Bioorg Med Chem Lett; 2004 Sep; 14(18):4719-22. PubMed ID: 15324894
[TBL] [Abstract][Full Text] [Related]
17. Aniline mustard analogues of the DNA-intercalating agent amsacrine: DNA interaction and biological activity.
Fan JY; Valu KK; Woodgate PD; Baguley BC; Denny WA
Anticancer Drug Des; 1997 Apr; 12(3):181-203. PubMed ID: 9154110
[TBL] [Abstract][Full Text] [Related]
18. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
Rene B; Fosse P; Khelifa T; Jacquemin-Sablon A; Bailly C
Mol Pharmacol; 1996 Feb; 49(2):343-50. PubMed ID: 8632768
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.
Gamage SA; Figgitt DP; Wojcik SJ; Ralph RK; Ransijn A; Mauel J; Yardley V; Snowdon D; Croft SL; Denny WA
J Med Chem; 1997 Aug; 40(16):2634-42. PubMed ID: 9258370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]